FDNRX
Price
$188.79
Change
+$0.74 (+0.39%)
Updated
Aug 21 closing price
Net Assets
28.74B
RGAFX
Price
$88.15
Change
+$0.79 (+0.90%)
Updated
Aug 21 closing price
Net Assets
342.42B
Interact to see
Advertisement

FDNRX vs RGAFX

FDNRX vs RGAFX Comparison Chart in %
View a ticker or compare two or three
VS
FDNRX vs. RGAFX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDNRX is a Buy and RGAFX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAFX has more cash in the bank: 342B vs. FDNRX (28.7B). RGAFX pays higher dividends than FDNRX: RGAFX (0.48) vs FDNRX (0.00). FDNRX was incepted earlier than RGAFX: FDNRX (18 years) vs RGAFX (24 years). FDNRX (1.02) is less costly to investors than RGAFX (0.34). RGAFX is a more actively managed with annual turnover of: 32.00 vs. FDNRX (29.61). RGAFX has a lower initial minimum investment than FDNRX: RGAFX (250) vs FDNRX (1000). RGAFX annual gain was more profitable for investors over the last year : 5.92 vs. FDNRX (1.77). FDNRX return over 5 years is better than : 22.02 vs. RGAFX (18.79).
FDNRXRGAFXFDNRX / RGAFX
Total Expense Ratio1.020.34300%
Annual Report Gross Expense Ratio1.020.34300%
Fund Existence18 years24 years-
Gain YTD6.9339.61272%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets28.7B342B8%
Annual Yield % from dividends0.000.48-
Returns for 1 year1.775.9230%
Returns for 3 years65.4048.73134%
Returns for 5 years22.0218.79117%
Returns for 10 years276.53104.75264%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWFX109.531.63
+1.51%
American Funds New World R-5
CMJAX52.540.36
+0.69%
Calvert US Mid Cap Core Rspnb Idx A
SVFDX100.610.67
+0.67%
Smead Value R1
PSSMX31.230.20
+0.64%
Principal SmallCap S&P 600 Index R3
CREYX11.05N/A
N/A
Columbia Real Estate Equity Inst3